Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a small platform update. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T23:40:19.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the study record without altering its content.
    Difference
    0.1%
    Check dated 2026-08-08T23:45:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.3 to v3.6.4, indicating an administrative update to the study record rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T13:19:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:27.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, representing a maintenance update to the ClinicalTrials.gov page; no substantive changes to the study details are indicated.
    Difference
    0.1%
    Check dated 2026-06-26T23:31:59.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Recruitment is now closed for the study, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revised version note, while a section header related to Intervention/Treatment appears to have been reorganized.
    Difference
    0.6%
    Check dated 2026-06-12T16:31:27.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.